Delivery Order SPE2DR25D1201-SPE2DR26FAKRT
- Not listed
- The Defense Logistics Agency awarded a $3,971.23 delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This is a firm fixed-price, non-set-aside contract with a completion date of January 29, 2026, and performance location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency awarded a $10,187.80 delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by February 2, 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a delivery order valued at $2,814.90 to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injections on January 29, 2026, with a completion date of January 30, 2026. This firm fixed-price, non-set-aside contract is being performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections, with a contract ceiling value of $4,612.77 and an ultimate completion date of January 29, 2026. This competitively awarded, non-set-aside firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $4,710.68 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 7, 2026, for the supply of Zepbound 10 mg/0.5 mL pens. This competitive, firm fixed-price delivery order is scheduled for ultimate completion on January 8, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $3,214.56 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This is a firm fixed-price, non-set-aside contract with a completion date of January 7, 2026, and performance will occur at the company's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical distributor serving federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $51,694.22 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectables on January 23, 2026. This firm fixed-price, non-set-aside contract is scheduled for completion by January 26, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $38,343.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 29, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pens. The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of January 30, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a $35,191.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. The order was competitively awarded with no set-aside designation and is scheduled for completion by January 16, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order valued at $40,828.16 from the Defense Logistics Agency (DLA) on January 29, 2026, for the supply of Zepbound 15 mg/0.5 ml pen injections. The contract represents a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation,...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAKRTDelivery Order
The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $34,651.45 on January 30, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This firm fixed-price, non-set-aside contract is scheduled for completion by February 2, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a task order execution under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor providing critical medical supplies to federal agencies, particularly the Department of Defense and Veterans Affairs. The company has demonstrated substantial capability to supply diverse pharmaceutical products including specialty medications, generic drugs, vaccines, and medical devices across multiple therapeutic domains through competitive procurement processes. This delivery order for Zepbound, a diabetes medication, reflects the company's ongoing role in supporting military and federal healthcare systems with essential pharmaceutical commodities on a firm fixed-price basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.7k | 1/29/26 |